PLACEBO-CONTROLLED PHASE II TRIAL OF SGS742 (GABAB RECEPTOR ANTAGONIST) IN SUCCINIC SEMIALDEHYDE DEHYDROGENASE (SSADH) DEFICIENCY, A DISORDER